{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:13:05Z","timestamp":1786122785625,"version":"build-2736575974"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,7]]},"DOI":"10.7759\/cureus.114115","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T12:28:42Z","timestamp":1786105722000},"source":"Crossref","is-referenced-by-count":0,"title":["Multidisciplinary Management of the Rare Coexistence of Multiple Endocrine Neoplasia Type 1 and Chronic Thromboembolic Pulmonary Hypertension: A Case Report"],"prefix":"10.7759","author":[{"given":"Gita","family":"Deb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Emmanuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny L","family":"Bacon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Hayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnaa031","article-title":"Multiple endocrine neoplasia type 1: latest insights","volume":"42","author":"Brandi ML","year":"2021","unstructured":"Brandi ML, Agarwal SK, Perrier ND, Lines KE, Valk GD, Thakker RV. Multiple endocrine neoplasia type 1: latest insights. Endocr Rev. 2021, 42:133-70. 10.1210\/endrev\/bnaa031","journal-title":"Endocr Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.m2024.0094","article-title":"Multiple endocrine neoplasia type 1","volume":"121","author":"Manoharan J","year":"2024","unstructured":"Manoharan J, Albers MB, Rinke A, Adelmeyer J, G\u00f6rlach J, Bartsch DK. Multiple endocrine neoplasia type 1. Dtsch Arztebl Int. 2024, 121:527-33. 10.3238\/arztebl.m2024.0094","journal-title":"Dtsch Arztebl Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0203","article-title":"Management impact: effects on quality of life and prognosis in MEN1","volume":"24","author":"Marini F","year":"2017","unstructured":"Marini F, Giusti F, Tonelli F, Brandi ML. Management impact: effects on quality of life and prognosis in MEN1. Endocr Relat Cancer. 2017, 24:T227-42. 10.1530\/ERC-17-0203","journal-title":"Endocr Relat Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02828-2020","article-title":"ERS statement on chronic thromboembolic pulmonary hypertension","volume":"57","author":"Delcroix M","year":"2021","unstructured":"Delcroix M, Torbicki A, Gopalan D, et al.. ERS statement on chronic thromboembolic pulmonary hypertension. Eur Respir J. 2021, 57:2002828. 10.1183\/13993003.02828-2020","journal-title":"Eur Respir J"},{"key":"ref5","unstructured":"Hypercalcaemia. (2026). Accessed. July 1, 2026: https:\/\/cks.nice.org.uk\/topics\/hypercalcaemia\/."},{"key":"ref6","unstructured":"Parathyroid hormone (PTH). (2024). Accessed. July 1, 2026: https:\/\/www.swlpath.nhs.uk\/tests-database\/parathyroid-hormone-pth\/."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.7230.1","article-title":"Genetics of multiple endocrine neoplasia type 1 syndrome: what's new and what's old","volume":"6","author":"Falchetti A","year":"2017","unstructured":"Falchetti A. Genetics of multiple endocrine neoplasia type 1 syndrome: what's new and what's old. F1000Res. 2017, 6:10. 10.12688\/f1000research.7230.1","journal-title":"F1000Res"},{"key":"ref8","article-title":"Multiple endocrine neoplasia type 1","author":"Singh G","year":"2023","unstructured":"Singh G, Mulji NJ, Jialal I. Multiple endocrine neoplasia type 1. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2008.01034.x","article-title":"MEN1 gene and its mutations: basic and clinical implications","volume":"100","author":"Tsukada T","year":"2009","unstructured":"Tsukada T, Nagamura Y, Ohkura N. MEN1 gene and its mutations: basic and clinical implications. Cancer Sci. 2009, 100:209-15. 10.1111\/j.1349-7006.2008.01034.x","journal-title":"Cancer Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker RV","year":"2012","unstructured":"Thakker RV, Newey PJ, Walls GV, et al.. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012, 97:2990-3011. 10.1210\/jc.2012-1230","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(25)00119-6","article-title":"Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practice","volume":"13","author":"Brandi ML","year":"2025","unstructured":"Brandi ML, Pieterman CRC, English KA, et al.. Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practice. Lancet Diabetes Endocrinol. 2025, 13:699-721. 10.1016\/S2213-8587(25)00119-6","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2025.02.001","article-title":"American Association of Clinical Endocrinology consensus statement on management of multiple endocrine neoplasia type 1","author":"Del Rivero J","year":"2025","unstructured":"Del Rivero J, Gangi A, Annes JP, et al.. American Association of Clinical Endocrinology consensus statement on management of multiple endocrine neoplasia type 1. Endocr Pract. 2025, 10.1016\/j.eprac.2025.02.001","journal-title":"Endocr Pract"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert M","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, et al.. 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022, 43:3618-731. 10.1093\/eurheartj\/ehac237","journal-title":"Eur Heart J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.03.029","article-title":"Evaluation and management of chronic thromboembolic pulmonary hypertension","volume":"164","author":"Yang J","year":"2023","unstructured":"Yang J, Madani MM, Mahmud E, Kim NH. Evaluation and management of chronic thromboembolic pulmonary hypertension. Chest. 2023, 164:490-502. 10.1016\/j.chest.2023.03.029","journal-title":"Chest"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/508754-multidisciplinary-management-of-the-rare-coexistence-of-multiple-endocrine-neoplasia-type-1-and-chronic-thromboembolic-pulmonary-hypertension-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T12:28:43Z","timestamp":1786105723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/508754-multidisciplinary-management-of-the-rare-coexistence-of-multiple-endocrine-neoplasia-type-1-and-chronic-thromboembolic-pulmonary-hypertension-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.114115","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,7]]}}}